Hualan Biological Engineering (002007) Stock Price, Fundamentals & Analysis

What 002007 does

Hualan Biological Engineering (002007) is a biotechnology company listed on the Shenzhen Stock Exchange. It operates in the healthcare sector and focuses on the research, development, production, and sale of biological products. The company offers a range of blood products, including human serum albumin, human prothrombin complex concentrate, human coagulation factor VIII, human fibrinogen, and freeze-dried human fibrin glue for surgical use. It also supplies various immunoglobulins and vaccines, such as influenza, H1N1, rabies, hepatitis B, and tetanus vaccines.

Key numbers explained

• 13.11 CNY is the current price of one share.
• The trailing P/E ratio of 29.8 shows how much investors pay per unit of past earnings; a higher number can suggest higher growth expectations.
• The forward P/E ratio of 11.7 is based on expected future earnings and is often used to compare valuation across companies.
• The dividend yield of 9.15% indicates the annual dividend payment as a percentage of the current share price.
• 226% of earnings are paid out as dividends, meaning the payout ratio exceeds 100% of reported earnings.
• The beta of 0.37 suggests the stock tends to be less volatile than the overall market.
• 11.72 – 17.09 is the lowest and highest price in the last 52 weeks, showing the recent trading range.
• -17.8% is the price change over the last 52 weeks, measured from one year ago to now.
• The debt-to-equity ratio of 3.1% compares the company's debt to its shareholders' equity.

What to watch

• Revenue trends: Hualan Biological Engineering reported trailing 12-month revenue of 4.36 mld. CNY, with a year-over-year decline of -13.5%.
• Profitability: the profit margin of 18.5% and operating margin of 14.7% show how much of revenue turns into profit and operating income.
• Return on equity: 6.5% indicates how effectively the company uses shareholders' equity to generate earnings.
• Market context: the stock trades on the Shenzhen Stock Exchange and can be compared with peers like Chongqing Zhifei Biological Products (300122) or Zhejiang NHU (002001).
• Dividend policy: the ex-dividend date is 15 iun. 2026, and the high payout ratio of 226% is a factor to monitor for sustainability.